Following successful trials, telemedicine solutions provider StethoMe has signed major deals with French telemedicine provider MaQuestionMedicale and Spanish telemedicine provider Home Doctor, which will enable the roll-out of StethoMe across Europe.
StethoMe’s innovative offering, which has been awarded full certification from the EU for its device and AI algorithms, monitors adults and children for early signs of respiratory issues at home – it is capable of detecting, classifying and analysing pathological sounds within the lungs using medical-grade precision. According to the company, StethoMe’s AI algorithms are 29 per cent more accurate than pulmonologists.
“Our team of technological and medical experts have devoted the last five years of R&D efforts to the creation of a smart wireless stethoscope,” said Wojciech Radomski, CEO of StethoMe. “At a time where medical services are under strain across the globe due to the Covid-19 pandemic, we believe the deals we have signed will contribute towards lessening the burden on healthcare systems and reduce the unnecessary spread of the disease.”
StethoMe is also reported to be developing remote lung and heart examinations for elderly patients with underlying medical conditions.
Professor Catherine Van Der Straeten, Head of the Health Innovation and Research Institute Ghent University Hospital, commented: “StethoMe is a solution that has been proven to help with the early screening of patients with lung problems from their home. In recent weeks, this has become even more important during the Covid-19 crisis situation across Europe. Telemedicine and the transfer of diagnostics to the patient’s home is the future, and the possibility of lung monitoring in patients with chronic diseases like COPD or asthma is a huge benefit. Thanks to solutions like StethoMe, telemedicine is constantly evolving.”